Sign in / Join Now
ETFs & Funds
Roy Manning III
has sold off alot. I would consider it a buy now. News on a Gout drug partner or their Hep
. patent could push the stock higher.
Add a reply...
Latest StockTalks »
people get BCRX breaking news and analysis by email alert.
Get email alerts on BCRX »
BioCryst Pharmaceuticals, Inc.
Get latest price
From other sites
BioCryst To Present At The Piper Jaffray Healthcare Conference November 30
at TheStreet (Nov 17, 2016)
BioCryst Reports Third Quarter 2016 Financial Results
at TheStreet (Nov 7, 2016)
BioCryst Announces Late Breaker Presentation Of Galidesivir (BCX4430) Nonclinical Results In Zika Virus Infection At IDWeek 2016
at TheStreet (Oct 26, 2016)
Commit To Purchase BioCryst Pharmaceuticals At $4, Earn 68.9% Annualized Using Options
at TheStreet (Oct 25, 2016)
BioCryst To Announce Third Quarter 2016 Financial Results November 7
at TheStreet (Oct 24, 2016)